In-vivo deposition measurement of formoterol and beclomethasone after inhalation of a single dose of the combination Formoterol plus BDP HFA pMDI (Foster, Chiesi) in healthy volunteers, asthmatic and COPD patients.
Latest Information Update: 27 Aug 2014
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Chiesi Farmaceutici
Most Recent Events
- 29 Aug 2011 New trial record